MK 4965

Known as: MK-4965, MK4965 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2008-2013
01220082013

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Diaryl ether family as one of the promising second generation HIV-1 non-nucleoside reverse transcriptase inhibitors has attracted… (More)
Is this relevant?
2011
2011
Next generation NNRTIs are sought which possess both broad spectrum antiviral activity against key mutant strains and a high… (More)
  • figure 2
  • figure 1
  • figure 3
  • figure 6
  • figure 5
Is this relevant?
2011
2011
Highly active antiretroviral therapy (HAART) significantly reduces human immunodeficiency virus (HIV) viral load and has led to a… (More)
Is this relevant?
Review
2010
Review
2010
HIV type-1 (HIV-1) non-nucleoside reverse transcriptase inhibitors (NNRTIs) are key drugs of highly active antiretroviral therapy… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 2
  • figure 3
Is this relevant?
2009
2009
Nonnucleoside reverse transcriptase inhibitors (NNRTIs) are the mainstays of therapy for the treatment of human immunodeficiency… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2008
2008
Non-nucleoside reverse transcriptase inhibitors (NNRTIs) have been shown to be a key component of highly active antiretroviral… (More)
Is this relevant?
Review
2008
Review
2008
Efavirenz non-nucleoside reverse transcriptase inhibitor (NNRTI)-based therapy or boosted protease inhibitor (PI)-based therapy… (More)
Is this relevant?